Soon-to-be-public Zoom is a Unicorn among Unicorns -- the company grew its top line over 100% last year and it managed to post a profit. We run through the company prospectus and see whether it is worth investing in ahead up its public debut:
Back in January, the FTC put out its antitrust case against Qualcomm and now we have Federal Judge Lucy Koh's decision. We explore the decision, what it means for Qualcomm and how it might radically change the business.
The real estate brokerage industry hasn’t changed much in decades, with high commissions and an opaque buying process. However, Redfin is changing the industry for the better, aiming to fulfill its mission to “Redefine real estate in the consumer’s favor.”
With a powerful value proposition, capable management, and a huge addressable market, Redfin is an up-and-coming Rulebreaker that investors should be receiving investors’ attention. Motley Fool Analyst Tim Beyers and Industry Focus Host Nick Sciple, both Redfin shareholders, break down Redfin’s competitive advantages, opportunities, and risks on this week’s episode.
We highlight two biotech stocks making oral presentations that could move their share price next month. Plus, Emily Flippen discusses an SEC proposal that could change reporting requirements for early stage biotechs.
Chinese coffee company Luckin has aggressive plans to add thousands of stores and it's willing to lose a lot of money to do that. That puts it in competition with Starbucks though there might be enough customers for both. In addition Target sold out of its exclusive Vineyard Vines collection and that may not be a good thing.
In the latest installment of our Between Two Fools interview series, host Jason Moser sits down with Prudential (NYSE: PRU) CFO Ken Tanji to talk about financial wellness and what the company is doing to try to improve the financial wellness of Americans. Plus, Fool.com contributor Matt Frankel, CFP talks about why Green Dot (NASDAQ: GDOT) plunged after its recent earnings report, and you’ll also hear what stocks are on our radar this week. All this and more on this week’s episode of Industry Focus: Financials.
We've got our hands on the first report for recently public Pinterest! We dive in and try and figure out why the stock sold off 10% after earnings, and check in on 2018 IPOs Upwork and Docusign to see how they're faring after their first year on the market.
If you took a hot shower this morning, there’s a good chance you got your hot water thanks to a product from A.O. Smith, America’s largest manufacturer of hot water heaters. Operating in an oligopoly market with growing demand as more of the world enters the middle class, A.O. Smith is up 9X over the last 10 years and counts itself among elite company as a dividend aristocrat. With shares down today on a recent short report from J Capital Research, Motley Fool Analyst John Rotonti joins the show to break down the investment opportunities and risks surrounding A.O. Smith today.
It's a battle of the big bio's on this episode of Industry Focus Healthcare. Is Gilead Sciences finally overcoming its hep C headwind? Is Amgen beating back biosimilars? We dig into the details as we discuss which of these biopharma behemoths delivered better first quarter results. Stocks: GILD, AMGN
You've undoubtedly been exposed to the multi-level marketing industry -- Facebook posts from people you went to high school with, phone calls asking you to come to Tupperware parties. Millions of Americans participate in the space, whether they call it "direct selling" "network marketing" or something else entirely. On this show, we explain why we won't invest in the industry, and how the average distributor tends to make out.
In this installment of Industry Focus: Financials, we sit down for a chat with Fool analyst T.J. Piggott. Then, host Jason Moser and Fool.com contributor Matt Frankel, CFP discuss the latest earnings from Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B), Square (NYSE: SQ), and Markel (NYSE: MKL). And, as always, the pair shares two stocks on the top of their watch list right now.
Get more great information on becoming a better investor -- free and straight to your inbox!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions.